3 ASX shares to help turn $100,000 into $1 million

Compounding and growth stocks can help you pull off what other people might think is a magic act.

| More on:
two magicians wearing dinner suits with bow ties wave their magic wands over a levitating bag with a dollars sign on it.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Turning $100,000 into a million bucks might sound like magic.

But no one needs supernatural powers if they use ASX shares and compounding to their advantage.

Allow me to introduce you to three stocks that I reckon could do the trick:

Temporary glitch, with long-term tailwinds still there

Johns Lyng Group Ltd (ASX: JLG) is an insurance claims repairer that has been a favourite of professional investors for years now.

And why not? The stock price has gained an astounding 366% over the past five years for an incredible compound annual growth rate (CAGR) of 36%.

With the world unfortunately seeing more extreme weather events due to global warming, building repair demand from insurers is on an upward trend.

The great news for those who haven't bought Johns Lyng yet is that the stock is in a bit of a dip right now.

The company put out a half-year result in February that didn't quite meet expectations, so the stock tumbled more than 13% in a single day.

Earnings before interest, taxes, depreciation, and amortisation (EBITDA)  were up, but sales revenue and net profit after tax (NPAT) both dipped.

Professional investors aren't panicking, though. They have their eyes on the prize in the long run.

Nine out of 11 analysts currently surveyed on the broking platform CMC Invest still reckon Johns Lyng is a buy. Eight of those recommend it as a strong add.

Look past the fear for these ASX shares

Similar to Johns Lyng, healthcare stock Neuren Pharmaceuticals Ltd (ASX: NEU) is also in a funk of late.

After snatching the crown as the S&P/ASX 200 Index (ASX: XJO)'s best performer in 2023, the stock has dived more than 16% to start 2024.

Much of that market fear has been driven by a short seller report that criticised the effectiveness of its Daybue drug.

But again, similar to Johns Lyng, the professional community is ignoring the noise. In fact, many analysts say the claims in the short report are just plain incorrect.

For example, the team at Blackwattle told its clients that the fear-mongering was "at odds with trial data and the real-life experience of medical specialists, patients, and their carers".

The analysts at Elvest Fund have also told its clients that their "thesis for Neuren Pharmaceuticals is unchanged".

"New CY24 Daybue sales guidance of US$370 to US$420 million (+120%) underpins another solid year of royalty and milestone revenue for Neuren."

Neuren shares are roughly an 18-bagger over the past half-decade, equating to a crazy CAGR of 78%.

The ASX shares riding high on AI

The investment case for data centre operator Nextdc Ltd (ASX: NXT) is straightforward.

Artificial intelligence (AI) is in hot demand. AI requires huge computing power. Those computers need to be housed somewhere.

This tailwind has already been recognised, with NextDC shares rocketing 75% over the past 12 months.

But many experts believe the world is at the start of its AI journey.

Fifteen analysts out of 18 currently surveyed on CMC Invest recommend buying NextDC shares.

Over the past five years, the stock has realised a 23% CAGR.

Of course, not all shares you buy will do as well as the above trio. 

But with proper diversification, it's not out of the question that your portfolio could achieve an average of 15% CAGR with the help of such massive winners.

So if you start with a $100,000 portfolio and then keep adding $1,000 to it each month, after 13 years, the nest egg will have expanded to $1,027,501.

And there it is, a million to your name.

Best wishes for your investments.

Motley Fool contributor Tony Yoo has positions in Johns Lyng Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Johns Lyng Group. The Motley Fool Australia has recommended Johns Lyng Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Investing Strategies

Five happy friends on their phones.
Dividend Investing

Buy Telstra and these ASX dividend shares next week

Analysts think these could be great income options for investors.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Index investing

Is the Vanguard Australian Shares ETF (VAS) just a big ASX bet on banks and miners?

Critics often point out that this ETF isn't diversified. Are they right?

Read more »

A young man wearing glasses writes down his stock picks in his living room.
Growth Shares

I think this ASX growth stock has market-beating potential

I'm betting that this investment will crush the ASX over the next few years.

Read more »

A woman shows her phone screen and points up.
Growth Shares

1 ASX 200 stock I'm buying hand over fist despite the market's pessimism

I’ve been building up my position in this compelling stock.

Read more »

Australian dollar notes inside the pocket on jeans, symbolising dividends.
Dividend Investing

How I would generate $20,000 of passive income from ASX shares each year

Here's how I would generate huge pay checks from the share market.

Read more »

Three generations of male family members enjoy the company as they plan future financial goals together on a trek outdoors.
Dividend Investing

3 'forever' ASX dividend shares to build your wealth

I think you can happily buy these three stocks to hold for your entire life today.

Read more »

A businessman holds a bolt of energy in both hands, indicating a share price rise in ASX energy companies
Dividend Investing

Does a 6.5% yield with relative stability sound good? Consider this ASX energy giant

This stock looks like a compelling choice for resilient income.

Read more »

Four young friends on a road trip smile and laugh as they sit on roof of their car.
Dividend Investing

Top ASX dividend shares to buy in April 2024

Winners are grinners!

Read more »